Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036460.pdf 0001181431-07-036460.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036468.pdf 0001181431-07-036468.rtf
May 31, 2007	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-07-126434.pdf 0001193125-07-126434.rtf 0001193125-07-126434.xls
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036469.pdf 0001181431-07-036469.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036465.pdf 0001181431-07-036465.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001209191-07-034029.pdf 0001209191-07-034029.rtf
May 31, 2007	FWP	FWP	Other	View HTML 0001193125-07-126478.pdf 0001193125-07-126478.rtf 0001193125-07-126478.xls
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036463.pdf 0001181431-07-036463.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036566.pdf 0001181431-07-036566.rtf
May 31, 2007	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001181431-07-036459.pdf 0001181431-07-036459.rtf

Data provided by Kaleidoscope.